When Gene Therapy Undergoes Review by Health Canada – Will The Experts Be Ready?
Spark Therapeutics’ FDA approved gene therapy, Luxturna, has a price tag – $850,000 (U.S.). Or $425,00 per eye for a rare type of blindness. The therapy is approved for persons with confirmed biallelic RPE65 mutation-associated retinal dystrophy.
Read More